Navigation Links
Carnegie Mellon scientists offer explanation for 'face blindness'
Date:11/25/2008

PITTSBURGHFor the first time, scientists have been able to map the disruption in neural circuitry of people suffering from congenital prosopagnosia, sometimes known as face blindness, and have been able to offer a biological explanation for this intriguing disorder.

Currently thought to affect roughly two percent of the population, congenital prosopagnosia manifests as the lifelong failure to recognize faces in the absence of obvious neurological damage, and in individuals with intact vision and intelligence.

Studying subjects aged 33 to 72 using diffusion tensor imaging and tractography, the team of scientists from Carnegie Mellon University, Kings College in London and Ben-Gurion University in Israel were able to show that, unlike that of normal brains, there was a reduction in the integrity of the white matter tracts in the brains of individuals with congenital prosopagnosic. Moreover, the extent of the reduced white matter circuitry was related to the severity of the behavioral impairment.

The results are reported in the Nov. 23 online issue of Nature Neuroscience.

White matter is one of the three main solid components of the central nervous system. The white matter is the tissue through which messages pass between different areas of grey matter within the nervous system. People with congenital prosopagnosia are not able to recognize faces, while the ability to recognize other objects may be relatively intact.

This discovery of reduced white matter circuitry could also lead to further understanding of other neurodevelopment disorders, such as developmental dyslexia, in which the same underlying neural alterations might be present. The findings are also important as congenital prosopagnosia is, in many cases, inherited and so studies of this sort can help us understand the relationship between genetics and cortical development.

So far, few successful therapies have been developed for affect
'/>"/>

Contact: Ken Walters
walters1@andrew.cmu.edu
412-268-2900
Carnegie Mellon University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Carnegie Mellon International Autism Symposium to Feature Groundbreaking Research, Oct. 17-18
2. Carnegie Mellon to host micromanufacturing conference
3. Trouble quitting?: A new Pitt-Carnegie Mellon smoking study may reveal why
4. Phoenix Health Systems Awarded Level 2 Carnegie Mellon University eSCM-SP Certification
5. Carnegie Corporation funds ASCB course on parasites for African scientists
6. Possible link between different forms of epilepsy found by Carnegie Mellon scientists
7. Carnegie Mellon researchers improve assessments of aortic aneurysms
8. Carnegie Mellon brain imaging study illustrates how remedial instruction helps poor readers
9. 2008 Gruber Genetics Prize awarded to Allan Spradling of Carnegie Institution
10. Establishing a Price for Carbon Emissions in the U.S. Would Spur Immediate Reductions in Energy Consumption and More Efficient Use of Power Generators, Study by Carnegie Mellon Researchers Shows
11. Carnegie Mellon engineering researchers automate analysis of protein patterns

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ts who have a prostate-specific antigen (PSA) valu...external beam radiation therapy (EBRT) are less li...d death, according to a study in the December 1 is...logy*Biology*Physics, the official journal of the ... PSA levels in a prostate cancer patient are moni...
(Date:12/2/2009)... National Pen ( www.pens.com ), a worldwide leadi...it is giving away 10,000 free business card pens. ...9 -- National Pen ( www.pens.com ), a worldwide le...y it is giving away 10,000 free business card pens...siness that no other company in the industry can d...
(Date:12/2/2009)... National Race Series to increase awareness of pr...n the importance of early detection , ...- Men, women, families, friends and neighbors &nda...articipate in the Rudolph Ramble 5K. The Rudolph ...ies , which was launched by the Prostate Conditio...
(Date:12/2/2009).... 2 The American Health...ectors today announced Alan F. Dowling, PhD, will ...ealth information management (HIM) leader. Dr. Do...cludes academia, systems management, strategic exp...t executive leadership. He is scheduled to take o...
(Date:12/2/2009)... - 4 State Campaign Features Small Business Owners...and Would Kill Jobs ,, WASHINGTON, Dec. 2 /PRN... summit scheduled for Thursday, Keeping Small Busi...ty, today announced a new $1 million 4 state TV ad... current health care legislation on small business...
Breaking Medicine News(10 mins):Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4
... of "Nicole,s Law" designed to ...an 28 Are local seniors,safe at Atria Senior Livi...,Assisted Living and SEIU Healthcare were asking a...ors that would warn,residents and staff of the pre...
...United Kingdom and the United States has revealed ...her to the next generation in a mouse model system... Genetics*, shows for the first time how mitochond...ngines present in each cell that produce adenosine...
...OWS, Ill., Jan. 26 The American,Society for Derma...rganization of leaders in the field of cosmetic an...e petition filed by Public Citizen with the,U.S. F...d use by trained physicians, believes that there i...
...f the,Chicago-based Health Capital Group, urged ho... look at their existing debt instruments, their,ob...ight of recent capital,market developments., Prob... in both debt pricing and access to capital challe...
... findings, experts say , , FRIDAY, Jan. 25...E and lutein could lower a woman,s risk of sight-r... observational study included more than 35,000 wom...of cataracts," said lead author William G. Christe...
...archers from Mayo Clinic in Rochester, Minnesota, ...c stents (SEPSs) in the treatment of benign esopha...in frequent stent migration and few cases of long-...or the use of SEPSs. The study appears in the Janu...
Other Medicine News:Health News:Activists Raise Alarm for Seniors, Deliver Carbon Monoxide Detectors to Atria Marland Place 2Health News:In silico modeling helps predict severity of mitochondrial disease 2Health News:American Society for Dermatologic Surgery Supports Current Labeling of Allergan's Botox(R) Products 2Health News:Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans 2Health News:Vitamin E, Lutein May Fight Cataracts 2Health News:Vitamin E, Lutein May Fight Cataracts 3Health News:Study examines self-expanding plastic stents in the treatment of benign esophageal conditions 2Health News:Study examines self-expanding plastic stents in the treatment of benign esophageal conditions 3
(Date:12/2/2009)..., LUND, Sweden, December 2 Der...atology and wound healing company "Pergamum" -,tod...ng results from a,clinical Phase I/IIa study. Derm...e (AMP) treatment for atopic dermatitis. Atopic de...ere dry skin and the skin,s weakened barrier,funct...
(Date:12/2/2009)...HAIFA, Isreal, December 2 /PRNewswire-FirstCall/ -...a leading developer of advanced,cardiovascular sur...s Board,of Directors approved a one-for-three forw...payable to Cardio Vascular Medical Device sharehol...course the estimated date the stock,split will be ...
(Date:12/2/2009)...M, Ala., Dec. 2 Adults are more ... cancer. For adults 65 and over, the odds of losin...an developing prostate cancer are one in six and o... nine. Vision loss threatens the overall health o... depression and inability to complete daily tasks....
Breaking Medicine Technology:Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Cardio Vascular Medical Device Announces Forward Stock Split 2Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Smallpox the death of a disease 49517 1Smallpox the death of a disease 49517 2Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 1Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 2Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 3Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 4Study of agricultural watersheds and carbon losses 8933 1Study of agricultural watersheds and carbon losses 8933 2
...ugh,Corporation (NYSE: SGP ) announced today that...esentations from about 60 clinical studies relatin...ted at the upcoming 44th,Annual Meeting of the Ame...go, May 30 - June 3. Data will be presented on TEM...ted liposomal doxorubicin,hydrochloride), INTRON(R...
...resented at the National Lipid Asso... N.J., May 30 Daiichi Sankyo, Inc.,announced toda...l studies,demonstrated that the addition of Welcho...ent regimens can lower A1C in patients with type 2...included all patients receiving,Welchol in these s...
Other Medicine Technology:About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: